Europe Today
Abivax $920 million cash haul lets it prepare for solo U.S. launch instead of relying on a buyer, CEO tells CNBC
Its latest fundraising round provides the French biotech with enough cash to finance operations through 2029.
This story was reported by Europe News. EUROPES curates Europe's most relevant coverage — read the full report at the original source.
Read full coverage at Europe News →